TY  - JOUR
AU  - Garcia-Guerrero, Estefania
AU  - Sanchez-Abarca, Luís I
AU  - Domingo, Esther
AU  - Ramos, Teresa L
AU  - Bejarano-Garcia, Jose A
AU  - Gonzalez-Campos, Jose A
AU  - Caballero-Velazquez, Teresa
AU  - Perez-Simon, Jose A
PY  - 2018
DO  - 10.3389/fimmu.2018.01971
UR  - http://hdl.handle.net/10668/12967
T2  - Frontiers in immunology
AB  - The relevance of the immune system in cancer has long been studied. Autologous adoptive T cell therapies, based on the use of tumor infiltrating lymphocytes (TILs), have made great progress in recent years for the treatment of solid tumors, especially...
LA  - en
PB  - Frontiers Research Foundation
KW  - T cell-tumor cell synapse
KW  - acute myeloid leukemia
KW  - cell selection
KW  - immunotherapy
KW  - tumor-specific T cells
KW  - Antigen Presentation
KW  - Antigens, Neoplasm
KW  - Cancer Vaccines
KW  - Cell Separation
KW  - Cells, Cultured
KW  - Cytotoxicity, Immunologic
KW  - Flow Cytometry
KW  - Humans
KW  - Immune Tolerance
KW  - Immunologic Surveillance
KW  - Immunotherapy, Adoptive
KW  - Leukemia, Myeloid, Acute
KW  - Lymphocyte Activation
KW  - Lymphocytes, Tumor-Infiltrating
KW  - Receptors, Antigen, T-Cell
KW  - T-Lymphocytes, Cytotoxic
KW  - Tumor Escape
KW  - Tumor Microenvironment
TI  - Selection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leukemic Cells: "Doublet Technology".
TY  - research article
VL  - 9
ER  -